Biogen Idec Has Built A Valuable Franchise Diversification is all well and good, but there's nothing wrong with a well-run company that does a few things very well. With an enviable franchise in multiple sclerosis, a promising pipeline and a host of pharmaceutical giants desperate for growth and operating leverage... Read On >> Related Reading: Big Values In Big Pharma Buy Into Atmel's Doubts As 2011 winds down, it looks as if few, if any, chip stocks will escape the malaise. Cavium (Nasdaq: CAVM) reported a slowdown in its business just a little while ago, and now Atmel (Nasdaq: ATML) has missed its revenue target and issued sharply lower guidance for the next quarter... Read On >> Related Reading: Should You Buy The Pullback? Big Dividends, Small Risk Over time dividends create enormous value. By some estimates, nearly one half of the total return from the S&P 500 over the past 100 years comes as a result of dividends. Dividends matter a lot, but only when they can be counted on year in and year out... Read On >> Related Reading: 4 ETFs On Fire Right Now From our advertisers...
|
| Analysis & Opinions Key market insight on major earnings releases, stock news and portfolio allocation strategies. | Sectors Diverse sector coverage including transportation, real estate, entertainment, education and more. | ETFs Real-time data and analysis on commodity, fixed income and equity exchange traded funds. | Free Tools Make informed decisions with our comprehensive suite of investing resources. | | |